Genomic Cancer Panel and Profiling Market Size, Share and Growth Analysis 2026 to 2035

Report Id: 2292 Pages: 180 Last Updated: 23 January 2026 Format: PDF / PPT / Excel / Power BI
Share With : linkedin twitter facebook

Segmentation of Genomic Cancer Panel and Profiling Market :

Genomic Cancer Panel and Profiling Market By Tissue Testing-

  • Solid Tissue Testing
  • Liquid Tissue Testing

Genomic Cancer Panel and Profiling Market

Genomic Cancer Panel and Profiling Market By Cancer Panel Type-

  • Single-Gene Panel
  • Multi-Gene Panel

Genomic Cancer Panel and Profiling Market By Cancer Type-

  • Lung Cancer
  • Breast Cancer
  • Colon Cancer
  • Prostate Cancer
  • Other Cancers

Genomic Cancer Panel and Profiling Market By Application-

  • Clinical
  • Research

Genomic Cancer Panel and Profiling Market By Technology-

  • Next-Generation Sequencing (NGS)
  • Polymerase Chain Reaction (PCR)
  • Fluorescence In-Situ Hybridization (FISH)
  • Immunohistochemistry (IHC)
  • Others

Genomic Cancer Panel and Profiling Market By End User-

  • Hospitals
  • Clinical and Diagnostic Laboratories
  • Research and Academic Institutes

Genomic Cancer Panel and Profiling Market By Region-

  • North America-
    • The US
    • Canada
  • Europe-
    • Germany
    • The UK
    • France
    • Italy
    • Spain
    • Rest of Europe
  • Asia-Pacific-
    • China
    • Japan
    • India
    • South Korea
    • South East Asia
    • Rest of Asia Pacific
  • Latin America-
    • Brazil
    • Argentina
    • Mexico
    • Rest of Latin America
  •  Middle East & Africa-
    • GCC Countries
    • South Africa
    • Rest of Middle East and Africa

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Genomic Cancer Panel and Profiling Market Snapshot

Chapter 4. Global Genomic Cancer Panel and Profiling Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: By Tissue Testing Estimates & Trend Analysis
5.1. By Tissue Testing, & Market Share, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Tissue Testing:

5.2.1. Solid Tissue Testing
5.2.2. Liquid Tissue Testing

Chapter 6. Market Segmentation 2: By Cancer Panel Type Estimates & Trend Analysis
6.1. By Cancer Panel Type & Market Share, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Cancer Panel Type:

6.2.1. Single-Gene Panel
6.2.2. Multi-Gene Panel

Chapter 7. Market Segmentation 3: By Cancer Type Estimates & Trend Analysis
7.1. By Cancer Type & Market Share, 2025 & 2035
7.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Cancer Type:

7.2.1. Lung Cancer
7.2.2. Breast Cancer
7.2.3. Colon Cancer
7.2.4. Prostate Cancer
7.2.5. Other Cancers

Chapter 8. Market Segmentation 4: By End-User Estimates & Trend Analysis
8.1. By End-User & Market Share, 2025 & 2035
8.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By End-User:

8.2.1. Hospitals
8.2.2. Clinical and Diagnostic Laboratories
8.2.3. Research and Academic Institutes
8.2.4. Other End Users

Chapter 9. Market Segmentation 5: By Technology Estimates & Trend Analysis
9.1. By Technology & Market Share, 2025 & 2035
9.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Technology:

9.2.1. Next-Generation Sequencing (NGS)
9.2.2. Polymerase Chain Reaction (PCR)
9.2.3. Fluorescence In-Situ Hybridization (FISH)
9.2.4. Immunohistochemistry (IHC)
9.2.5. Others

Chapter 10. Market Segmentation 6: By Application Estimates & Trend Analysis
10.1. By Application & Market Share, 2025 & 2035
10.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following By Application:

10.2.1. Clinical
10.2.2. Research

Chapter 11. Genomic Cancer Panel and Profiling Market Segmentation 7: Regional Estimates & Trend Analysis
11.1. North America

11.1.1. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Tissue Testing, 2022-2035
11.1.2. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Panel Type, 2022-2035
11.1.3. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Cancer Type, 2022-2035
11.1.4. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By End-User, 2022-2035
11.1.5. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Technology, 2022-2035
11.1.6. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts By Application, 2022-2035
11.1.7. North America Genomic Cancer Panel and Profiling Market revenue in US$ Million estimates and forecasts by country, 2022-2035

11.2. Europe

11.2.1. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2022-2035
11.2.2. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2022-2035
11.2.3. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2022-2035
11.2.4. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2022-2035
11.2.5. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2022-2035
11.2.6. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2022-2035
11.2.7. Europe Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035

11.3. Asia Pacific

11.3.1. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, 2022-2035
11.3.2. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, 2022-2035
11.3.3. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, 2022-2035
11.3.4. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, 2022-2035
11.3.5. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, 2022-2035
11.3.6. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, 2022-2035
11.3.7. Asia Pacific Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035

11.4. Latin America

11.4.1. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2022-2035
11.4.2. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2022-2035
11.4.3. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2022-2035
11.4.4. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2022-2035
11.4.5. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2022-2035
11.4.6. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2022-2035
11.4.7. Latin America Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035

11.5. Middle East & Africa

11.5.1. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Tissue Testing, (US$ Million) 2022-2035
11.5.2. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Panel Type, (US$ Million) 2022-2035
11.5.3. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Cancer Type, (US$ Million) 2022-2035
11.5.4. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By End-User, (US$ Million) 2022-2035
11.5.5. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Technology, (US$ Million) 2022-2035
11.5.6. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million By Application, (US$ Million) 2022-2035
11.5.7. Middle East & Africa Genomic Cancer Panel and Profiling Market revenue in US$ Million by country, 2022-2035

Chapter 12. Competitive Landscape
12.1. Major Mergers and Acquisitions/Strategic Alliances
12.2. Company Profiles

12.2.1. Agilent Technologies, Inc.
12.2.2. ARUP Laboratories
12.2.3. Burning Rock DX
12.2.4. Caris Life Sciences
12.2.5. Thermo Fisher Scientific, Inc.
12.2.6. Danaher Corporation (Integrated DNA Technologies, Inc.)
12.2.7. Exact Sciences Corporation
12.2.8. F. Hoffmann-La Roche Ltd
12.2.9. Fulgent Genetics
12.2.10. Genecast Biotechnology Co., Ltd
12.2.11. Illumina, Inc.
12.2.12. Invitae Corporation

Research Design and Approach

This study employed a multi-step, mixed-method research approach that integrates:

  • Secondary research
  • Primary research
  • Data triangulation
  • Hybrid top-down and bottom-up modelling
  • Forecasting and scenario analysis

This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.

Secondary Research

Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.

Sources Consulted

Secondary data for the market study was gathered from multiple credible sources, including:

  • Government databases, regulatory bodies, and public institutions
  • International organizations (WHO, OECD, IMF, World Bank, etc.)
  • Commercial and paid databases
  • Industry associations, trade publications, and technical journals
  • Company annual reports, investor presentations, press releases, and SEC filings
  • Academic research papers, patents, and scientific literature
  • Previous market research publications and syndicated reports

These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.

Secondary Research

Primary Research

Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.

Stakeholders Interviewed

Primary interviews for this study involved:

  • Manufacturers and suppliers in the market value chain
  • Distributors, channel partners, and integrators
  • End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
  • Industry experts, technology specialists, consultants, and regulatory professionals
  • Senior executives (CEOs, CTOs, VPs, Directors) and product managers

Interview Process

Interviews were conducted via:

  • Structured and semi-structured questionnaires
  • Telephonic and video interactions
  • Email correspondences
  • Expert consultation sessions

Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.

Data Processing, Normalization, and Validation

All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.

The data validation process included:

  • Standardization of units (currency conversions, volume units, inflation adjustments)
  • Cross-verification of data points across multiple secondary sources
  • Normalization of inconsistent datasets
  • Identification and resolution of data gaps
  • Outlier detection and removal through algorithmic and manual checks
  • Plausibility and coherence checks across segments and geographies

This ensured that the dataset used for modelling was clean, robust, and reliable.

Market Size Estimation and Data Triangulation

Bottom-Up Approach

The bottom-up approach involved aggregating segment-level data, such as:

  • Company revenues
  • Product-level sales
  • Installed base/usage volumes
  • Adoption and penetration rates
  • Pricing analysis

This method was primarily used when detailed micro-level market data were available.

Bottom Up Approach

Top-Down Approach

The top-down approach used macro-level indicators:

  • Parent market benchmarks
  • Global/regional industry trends
  • Economic indicators (GDP, demographics, spending patterns)
  • Penetration and usage ratios

This approach was used for segments where granular data were limited or inconsistent.

Hybrid Triangulation Approach

To ensure accuracy, a triangulated hybrid model was used. This included:

  • Reconciling top-down and bottom-up estimates
  • Cross-checking revenues, volumes, and pricing assumptions
  • Incorporating expert insights to validate segment splits and adoption rates

This multi-angle validation yielded the final market size.

Forecasting Framework and Scenario Modelling

Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.

Forecasting Methods

  • Time-series modelling
  • S-curve and diffusion models (for emerging technologies)
  • Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
  • Price elasticity models
  • Market maturity and lifecycle-based projections

Scenario Analysis

Given inherent uncertainties, three scenarios were constructed:

  • Base-Case Scenario: Expected trajectory under current conditions
  • Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
  • Conservative Scenario: Slow adoption, regulatory delays, economic constraints

Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.

Name field cannot be blank!
Email field cannot be blank!(Use email format)
Designation field cannot be blank!
Company field cannot be blank!
Contact No field cannot be blank!
Message field cannot be blank!
2026
Security Code field cannot be blank!

Frequently Asked Questions

Genomic Cancer Panel and Profiling Market Size is valued at USD 10.56 Bn in 2025 and is predicted to reach USD 23.39 Bn by the year 2035

Genomic Cancer Panel and Profiling Market is expected to grow at a 8.4% CAGR during the forecast period for 2026 to 2035.

Agilent Technologies, Inc., ARUP Laboratories, Burning Rock DX, Caris Life Sciences, Thermo Fisher Scientific, Inc., Danaher Corporation (Integrated DNA Technologies, Inc.), Exact Sciences Corporation, F. Hoffmann-La Roche Ltd, Fulgent Genetics, Genecast Biotechnology Co., Ltd, Illumina, Inc., Invitae Corporation, Qiagen N.V., NeoGenomics, Inc., Sysmex Corporation, HTG Molecular Diagnostics, Inc., Predictive Oncology, Inc., NanoString Technologies, Inc., Guardant Health, Inc., Foundation Medicine, Genscript Biotech Corporation, Tempus Labs, Hologic, Inc., and Others

Tissue Testing (Solid Tissue Testing, Liquid Tissue Testing), By Cancer Panel Type (Single-Gene Panel, Multi-Gene Panel), By Cancer Type (Lung Cancer, Breast Cancer, Colon Cancer, Prostate Cancer, Other Cancers), Application, Technology and End User.

North American region is leading the Genomic Cancer Panel and Profiling Market.

Report License Selection

Determine the Appropriate License for your Report

Get Sample Report Enquiry Before Buying